Rachid Izzar - Dec 2, 2021 Form 4 Insider Report for BIOGEN INC. (BIIB)

Role
Head of Alzheimer's Disease
Signature
/s/ Wendell Taylor, attorney-in-fact for Rachid Izzar
Stock symbol
BIIB
Transactions as of
Dec 2, 2021
Transactions value $
$47,304
Form type
4
Date filed
12/6/2021, 03:14 PM
Previous filing
Jul 29, 2021
Next filing
Feb 14, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIIB Common Stock Options Exercise $85K +372 +41.38% $228.52 1.27K Dec 2, 2021 Direct
transaction BIIB Common Stock Tax liability -$37.7K -165 -12.98% $228.52 1.11K Dec 2, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIIB Restricted Stock Unit Options Exercise $0 -372 -21.7% $0.00 1.34K Dec 2, 2021 Common Stock 372 $0.00 Direct F1
transaction BIIB Restricted Stock Unit Other $0 -484 -36.07% $0.00 858 Dec 2, 2021 Common Stock 484 $0.00 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This award was granted to the reporting person on December 2, 2019. The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date]).
F2 This number represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested.